Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
March 4, 1994
In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone
F Haviv, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry
|
October 16, 1992
Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics
F Haviy, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry
|
February 5, 1993
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists
F Haviv, T D Fitzpatrick, R E Swenson, et al.
Cell Metabolism
|
October 18, 2016
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y Gui, Lucas B Sullivan, Alba Luengo, et al.
Journal of Medicinal Chemistry
|
April 2, 1993
The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists
F Haviv, T D Fitzpatrick, C J Nichols, et al.
Dermatology and Therapy
|
September 2, 2015
A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma
Anna W Steenrod, Emily Nash Smyth, Elizabeth N Bush, et al.
Oncology Nursing Forum
|
January 1, 1997
Quality of life and the cancer experience: the state-of-the-knowledge
C R King, M Haberman, D L Berry, et al.
Nature Cell Biology
|
June 27, 2018
Aspartate is an endogenous metabolic limitation for tumour growth
Lucas B Sullivan, Alba Luengo, Laura V Danai, et al.
Journal of Medicinal Chemistry
|
March 16, 1992
Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation
T W von Geldern, T W Rockway, S K Davidsen, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues
John T Randolph, Philip Waid, Charles Nichols, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
March 4, 1994
In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone
F Haviv, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry
|
October 16, 1992
Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics
F Haviy, T D Fitzpatrick, C J Nichols, et al.
Journal of Medicinal Chemistry
|
February 5, 1993
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists
F Haviv, T D Fitzpatrick, R E Swenson, et al.
Cell Metabolism
|
October 18, 2016
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y Gui, Lucas B Sullivan, Alba Luengo, et al.
Journal of Medicinal Chemistry
|
April 2, 1993
The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists
F Haviv, T D Fitzpatrick, C J Nichols, et al.
Dermatology and Therapy
|
September 2, 2015
A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma
Anna W Steenrod, Emily Nash Smyth, Elizabeth N Bush, et al.
Oncology Nursing Forum
|
January 1, 1997
Quality of life and the cancer experience: the state-of-the-knowledge
C R King, M Haberman, D L Berry, et al.
Nature Cell Biology
|
June 27, 2018
Aspartate is an endogenous metabolic limitation for tumour growth
Lucas B Sullivan, Alba Luengo, Laura V Danai, et al.
Journal of Medicinal Chemistry
|
March 16, 1992
Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation
T W von Geldern, T W Rockway, S K Davidsen, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues
John T Randolph, Philip Waid, Charles Nichols, et al.
Page
of 9